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Purpose. To compare the risk for diabetes in each of 4 categories of metabolic health and BMI. Methods. Participants were
drawn from the Cameron County Hispanic Cohort, a randomly selected Mexican American cohort in Texas on the US-Mexico
border. Subjects were divided into 4 phenotypes according to metabolic health and BMI: metabolically healthy normal weight,
metabolically healthy overweight/obese, metabolically unhealthy normal weight, and metabolically unhealthy overweight/obese.
Metabolic health was defined as having less than 2 metabolic abnormalities. Overweight/obese status was assessed by BMI higher
than 25 kg/m2 . Diabetes was defined by the 2010 ADA definition or by being on a diabetic medication. Results. The odds ratio
for diabetes risk was 2.25 in the metabolically healthy overweight/obese phenotype (95% CI 1.34, 3.79), 3.78 (1.57, 9.09) in the
metabolically unhealthy normal weight phenotype, and 5.39 (3.16, 9.20) in metabolically unhealthy overweight/obese phenotype
after adjusting for confounding factors compared with the metabolically healthy normal weight phenotype. Conclusions. Metabolic
health had a greater effect on the increased risk for diabetes than overweight/obesity. Greater focus on metabolic health might be
a more effective target for prevention and control of diabetes than emphasis on weight loss alone.

1. Introduction
The proportion of overweight/obese adults in the US
increased between 1980 and 2013 from 28.8% to 36.9% in men
and from 29.8% to 38.0% in women [1]. Overweight/obesity
increases the risk for type 2 diabetes mellitus [2, 3]. However,
being metabolically unhealthy also increases the risk for type
2 diabetes [4–6]. Though these findings suggest that the
risk for type 2 diabetes associated with overweight/obesity
is influenced by the coexistence of metabolic abnormalities,
the independent impact of these two conditions is unclear.
Metabolically unhealthy normal weight (MUHNW) subjects
are individuals with normal weight but with metabolic
abnormalities [7, 8], but the phenotype is ill-defined. Among
normal weight individuals aged 20 years or older in the Third
National Health and Nutrition Examination Survey, 4.6%
of men and 6.2% of women had three or more metabolic

abnormalities [9]. Because MUHNW subjects are not overweight or obese, they may not be aware of their risks and
may be missed and therefore may not benefit from adequate
prevention. Nevertheless, MUHNW carries a significant risk
for cardiovascular diseases [10, 11] and mortality [12]. The
findings from several studies have shown the increased risk
of diabetes in MUHNW individuals [4–6] compared with
metabolically healthy normal weight (MHNW) individuals
in different ethnicities, but only one study was conducted in
Mexican Americans [6].
There is no consensus on the risk presented by the
metabolically healthy overweight/obese (MHOW) phenotype [4, 5]. Evidence regarding the risk of diabetes associated
with the MHOW phenotype is also uncertain. It has been
reported that MHOW individuals may be more likely to
develop incident diabetes compared with normal weight individuals [4–6]; however data from Kangbuk Samsung Health
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Study of more than 6 thousand individuals did not show a
significant association with diabetes [5] and data in Mexican
Americans is in any event limited [6]. Although metabolically
unhealthy overweight/obese (MUHOW) subjects showed a
higher risk of diabetes than MHNW phenotype [4–6, 13],
only a few studies compared the diabetes risk between
MUHOW, MUHNW, MHOW, and MHNW phenotypes [4–
6] and only one was conducted in Mexican Americans [6].
Mexican Americans have higher prevalence of diabetes,
overweight/obesity, and metabolic disturbances than nonHispanic Whites [14–16]. The objective of this study was
to compare the risk for diabetes among the 4 phenotypes
divided by metabolic health and overweight/obesity status in
a randomly selected cohort of Mexican American subjects.

2. Materials and Methods
2.1. Study Participants. This study was approved by the
Committee for the Protection of Human Subjects of the
UT Health, Houston and the Institutional Review Board
of the University of the Texas Health Science Center,
San Antonio. All study participants gave written informed
consent. This cross-sectional analysis used data from the
Cameron County Hispanic Cohort (CCHC), a homogenous
community-dwelling Mexican American ongoing cohort
study [17, 18]. Study subjects were recruited from randomly
selected blocks according to the 2000 Census as described
previously [17, 18]. At the baseline survey conducted between
2003 and 2014, 3,257 participants aged 18 years or older were
recruited from their households in predominantly Mexican
American cities along the Rio Grande border with Mexico.
To reduce the effect of type I diabetes on the results, the
participants who had diabetes before 18 years were excluded
(𝑛 = 10).
All subjects responded to a detailed baseline survey of
demographic characteristics, lifestyle including diet, physical
activity, family, and medical history, and other exposures.
Participants were asked to fast for at least 10 hours overnight
before a clinic visit at the clinical research unit. Anthropometric measurements, including current weight, height, and
circumferences of the waist and hip, were also taken [17, 18].
Weight was measured to the nearest tenth of a kilogram
and height to the nearest tenth of a centimeter. Body mass
index (BMI) was calculated as weight in kilograms divided
by height squared in meters (kg/m2 ). Waist circumference
(WC) was measured at the level of the umbilicus and hip
circumference (HC) at the level of maximum width of
the buttocks with participants in a standing position and
breathing normally, to the nearest 0.2 cm. Waist-to-hip ratio
(WHR) was calculated as WC divided by HC [17]. Body fat
percentage was estimated using the resistance values from
the Quantum X bioelectric body composition analyzer with
the sex-specific equations from Sun et al. [19]. The average of
3 blood pressure (BP) measurements taken 5 minutes apart
were used.
All participants completed a detailed baseline survey
that collected information on demographic characteristics,
lifestyle and dietary histories, medical history, and other
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exposures. Physical activity was assessed using the International Physical Activity Questionnaire (IPAQ) short form
[20]; reported minutes of physical activity per week were
weighted by a metabolic equivalent (MET, multiples of resting
energy expenditure) resulting in a physical activity estimate
expressed as MET-minutes per week [20]. Physical activity
energy expenditure was estimated using standard metabolic
equivalent (MET) values [20].
2.2. Laboratory Measurements. All participants donated a
blood sample at baseline. After collection, samples were
placed on ice and centrifuged within 30 minutes of collection. Following processing and aliquoting, all samples were
stored at −80∘ C until laboratory analyses were conducted.
Laboratory studies performed included fasting lipid panel,
hemoglobin (Hb) A1c, fasting plasma glucose, and fasting
serum insulin. Homeostasis model assessment insulin resistance index (HOMA-IR) was calculated as fasting glucose
(mg/dL)/18 × fasting insulin (mU/L)/22.5 [21]. High sensitivity C-reactive protein (CRP) levels were measured using
Quantikine ELISA kit (R & D Systems, Inc., Minneapolis,
USA).
2.3. Identification of the Overweight/Obese and Metabolic
Health. Participants were categorized as overweight/obese
or with normal weight using a BMI cutoff of 25.0 kg/m2 [1]
and then were further categorized as metabolically healthy
or unhealthy. Metabolic health was defined as having <2
of the following metabolic abnormalities: systolic BP (SBP)
≥ 130 mmHg and/or diastolic BP (DBP) ≥ 85 mmHg or
on antihypertensive medication; triglyceride ≥ 150 mg/dL;
high-density lipoprotein cholesterol < 40 mg/dL in men or
<50 mg/dL in women; or HOMA-IR value > 90th percentile
[22, 23]. Waist circumference was not included due to
its high correlation with BMI [22]. To avoid bias we did
not use blood glucose levels nor diabetes medication in
the definition of metabolic health so as to compare the
risk for diabetes in 4 phenotypes of metabolic health and
BMI.
According to the above criteria, participants were divided
into four phenotypes:
(1) MHNW: metabolically healthy, normal weight: BMI
< 25 kg/m2 and <2 metabolic risk factor;
(2) MHOW: metabolically healthy, overweight/obese:
BMI ≥ 25 kg/m2 and <2 metabolic risk factor;
(3) MUHNW: metabolically unhealthy, normal weight:
BMI < 25 kg/m2 and ≥2 metabolic risk factor;
(4) MUHOW: metabolically unhealthy, overweight/
obese: BMI ≥ 25 kg/m2 and ≥2 metabolic risk factor.
2.4. Identification of Diabetes. Diabetes was identified by
the 2010 definition of diabetes of the American Diabetes
Association [24] or the participants reporting being told by
a health care provider that they had diabetes or if they were
taking hypoglycemic medication.
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2.5. Statistical Analysis. Descriptive results and the models
reported in this paper were adjusted for the probability of
sampling using weights taking into consideration clustering
effects arising from the census block and household [17]. Logtransformation was conducted to normalize the distribution
of the biomarkers studied as appropriate. Survey-weighted
linear regression was used to obtain the 𝑡-test statistics to
compare phenotypes and to be used for multiple pairwise
mean comparisons for continuous data. Survey-weighted chisquare test was used to obtain Rao-Scott 𝐹 adjusted chisquare statistic to compare phenotypes for categorical data.
Survey-weighted logistic regression modeling was performed
to estimate the odds ratios (ORs) for diabetes risk and
their 95% confidence intervals (CIs) by the metabolic health
and overweight/obese phenotype phenotypes adjusting for
other covariates. Initially, a multivariable survey-weighted
logistic regression model was created to identify independent
factors associated with diabetes, among variables including
the overweight/obese phenotypes, age, gender, education,
reported minutes of physical activity per week, servings
of fruits and vegetables per day, and alcohol drinking and
cigarette smoking status. Variables that were not significant
and were not confounders were excluded from the final
model. The interaction effects between the independent variables were tested. The analysis involved in physical activity
and dietary data was conducted in 2,044 participants because
the interview was only administered in these subjects.
To compare the risk of diabetes in different metabolic
health and overweight/obese phenotypes, we also used a
restricted cubic spline logistic regression analysis [25] to
evaluate the risk of diabetes with age (𝑃 < 0.0001 for
all participants) stratified by metabolic health and overweight/obese phenotypes. Knots were placed at the 5th, 50th,
and 95th percentiles of the distribution of age at enrollment.
We excluded participants whose age at enrollment was below
20 or above 70 from the restricted cubic spline model to
minimize the influence of outliers.
Sensitivity analyses were performed including fasting glucose > 100 mg/dL or on hypoglycemic medication as a component for the definition of metabolic health (metabolically
healthy, 0 metabolic abnormalities; metabolically unhealthy,
≥2 metabolic abnormalities) [22, 23]. Participants were categorized as overweight (25–29.9 kg/m2 ) or obese (≥30 kg/m2 )
using BMI cutoffs of 25.0 and 30 kg/m2 [1] and separate
analyses by overweight and obesity were also conducted.
Statistical analyses were carried out by using SAS version 9.3
(SAS Institute, Cary, NC). All statistical tests were based on
two-sided probability.

3. Results
At the time of this study a total of 3,257 individuals were
enrolled in the CCHC, 2,893 participants from Brownsville
and 242 participants from Harlingen (Lower Rio Grande
Valley) and 138 participants from Laredo (Webb County),
Texas. Among 3,247 remaining participants after excluding
10 subjects who developed diabetes before 18 years of age (to
minimize potential type I diabetes), 475 subjects (14.6%) were
classified as MHNW, 1,594 (49.1%) as MHOW, 72 (2.2%) as
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MUHNW, and 1,106 (34.1%) as MUHOW (Table 1). Mean
age of this subset was 46 years; 34% were male. A total of
36.3% (𝑛 = 1,178) were classified as metabolically unhealthy.
Detailed characteristics by overweight, obesity, and metabolic
health were shown in Supplemental Table 1 (see Supplementary Material available online at http://dx.doi.org/10.1155/
2016/4094876).
Metabolically unhealthy phenotypes showed significantly
elevated mean values of total cholesterol, triglycerides, highdensity lipid cholesterol (HDLC), fasting glucose and insulin,
HOMA IR, HbA1c, CRP, and blood pressure compared with
metabolically healthy phenotypes. They were more likely
to be older, cigarette smokers and unemployed, less well
educated, and less likely to meet the recommended guidelines
for physical activity of more than 600 MET-minutes/week.
They had lower household income but more frequent family
history of diabetes (all Ps < 0.05). There was no difference
in gender between metabolically unhealthy and healthy
phenotypes (Table 1).
Overweight/obese phenotypes were also more likely to be
older, less well educated, and cigarette smoking, had lower
incomes but more frequent family history of diabetes, and
showed significantly elevated mean values of total cholesterol,
triglycerides, HDLC, fasting glucose and insulin, HOMA IR,
HbA1c, CRP, blood pressure, BMI, WC, WHR, and body fat
percentage compared with normal weight phenotypes (all
Ps < 0.05). There was no difference in gender, employment
status, and physical activity between overweight/obese and
normal weight phenotypes (Table 1).
Seventy-two participants of the cohort (2.2%) were classified as metabolically unhealthy, normal weight. Compared
with other three phenotypes, MUHNW subjects were more
likely to be older, unemployed, and cigarette smoking, were
least likely to meet the recommended guidelines for physical
activity of more than 600 MET-minutes/week, and had least
income and worst mean values in total cholesterol, SBP, and
HbA1c (all Ps < 0.05) (Table 1).
A total of 878 (27.04%) participants had diabetes
(Table 2). Among the four phenotypes the MHNW phenotype had the lowest rates of diabetes (12%) and the
MUHOW phenotype had the highest (40.3%) (𝑃 < 0.0001)
(Figure 1). Metabolically unhealthy subjects showed significantly higher diabetes prevalence than metabolically healthy
subjects (40.3% versus 19.6%; 𝑃 < 0.0001). Overweight/obese
phenotypes showed significantly higher diabetes prevalence
than normal weight phenotypes (29.4% versus 15.2%; 𝑃 <
0.0001).
Overweight/obese individuals showed an OR of having
diabetes of 2.06 (95% CI: 1.33–3.21) after adjusting for age and
metabolic health. Poor metabolic health was positively related
to the increased risk of diabetes (OR = 2.46; 95% CI: 1.88–3.21)
after adjusting for age and overweight/obesity, suggesting
that being metabolically unhealthy carried a higher risk for
diabetes than being overweight/obese (2.46 versus 2.06).
The risk of diabetes by categories of BMI and metabolic
status is shown in Table 2. In a multivariable adjusted logistic
regression model with diabetes as the dependent variable,
MHOW subjects showed an OR of having diabetes of 2.25
(95% CI 1.34–3.79), MUNW individuals showed an OR of

Total
(𝑛 = 3247)
544 (38.09)
822 (51.57)
813 (51.00)
192 (12.05)
67 (4.20)
222 (13.93)
478 (29.99)
601 (37.70)
876 (54.96)
44.57 (0.78)
24563 (1284.32)
10.71 (0.17)
2384.2 (646.06)
1572.37 (274.14)
182.76 (1.67)
124.83 (3.51)
49.41 (0.44)
109.86 (1.49)
31.56 (0.24)
103.35 (0.52)
0.93 (0.003)
36.51 (0.65)
2.18 (1.09)
113.3 (0.54)
70.07 (0.35)
11.47 (1.02)
101.49 (1.01)
2.89 (1.02)
5.31 (1.01)

139 (28.64)
242 (50.95)
195 (41.05)
48 (10.11)
9 (1.89)
64 (13.47)
119 (25.05)
186 (39.16)
165 (34.74)
40.59 (1.90)
19617 (1724.54)
11.58 (0.39)
1393.1 (445.87)
1115.31 (261.88)
176.41 (2.62)
98.8 (3.25)
53.73 (1.06)
103.14 (2.28)
22.44 (0.16)
84.69 (0.91)
0.88 (0.01)
25.80 (0.88)
1.48 (1.08)
107.53 (1.38)
66.24 (1.18)
7.69 (1.06)
93.69 (1.01)
1.82 (1.07)
5.05 (1.02)

53.96 (3.04)
14043 (1351.98)
10.24 (0.69)
167.15 (107.01)
67.47 (48.29)
188.24 (7.55)
195.41 (13.61)
42.67 (1.32)
108.64 (6.82)
22.53 (0.47)
86.98 (0.91)
0.89 (0.01)
27.69 (3.39)
2.77 (1.27)
126.04 (3.38)
71.89 (1.51)
9.12 (1.14)
111.05 (1.06)
2.53 (1.17)
6.23 (1.04)

25 (33.75)
25 (34.72)
37 (51.39)
1 (1.39)
4 (5.56)
14 (19.44)
21 (29.17)
20 (27.78)
41 (56.94)

49.80 (1.27)
20561 (1084.07)
9.56 (0.25)
1447.24 (591.89)
768.36 (151.68)
187.66 (1.85)
238.58 (7.11)
39.64 (0.45)
105.83 (1.72)
34.08 (0.32)
110.3 (0.67)
0.96 (0.003)
38.33 (0.76)
5.75 (1.05)
125.42 (0.99)
74.83 (0.57)
17.29 (1.03)
119.10 (1.02)
5.05 (1.03)
5.93 (1.02)

400 (33.63)
529 (47.83)
648 (58.59)
96 (8.68)
33 (2.98)
195 (17.63)
366 (33.09)
423 (38.25)
667 (60.31)

<0.0001
<0.0001
<0.0001
0.0002
<0.0001
<0.0001
<0.0001
<0.0001
0.06
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

0.054
0.03
<0.0001
0.02
0.32
0.02
0.0003
0.79
<0.0001

Metabolically healthy
Metabolically unhealthy
Normal weight Overweight/obese Normal weight Overweight/obese P value
(𝑛 = 475, 14.63%) (𝑛 = 1594, 49.09%) (𝑛 = 72, 2.22%) (𝑛 = 1106, 34.06%)

2

LDL: low-density lipoprotein; Hb: hemoglobin; HDL: high-density lipoprotein; HOMA IR: homeostatic model assessment insulin resistance; MET: metabolic equivalent.
All descriptive results and the models were adjusted for the probability of sampling using weights taking into consideration clustering effects arising from the same census block and household. Linear regression
models were used for continuous variables and Rao-Scott 𝐹 adjusted chi-square statistic for categorical variables.
3
Geometric concentrations.

1

Categorical variables, 𝑛 (%)
Men
1108 (34.11)
Employed
1618 (49.83)
Education, below high school
1693 (52.14)
Met minimum recommendations for physical activity of ≥ 600 MET-minutes/week 337 (10.38)
Met recommendations of ≥ 5 servings of fruit and vegetables per day
113 (3.48)
Current smokers
495 (15.24)
Ever smokers
984 (30.3)
Ever alcohol drinkers
1230 (37.88)
Family history of diabetes
1749 (53.87)
Continuous variables, mean (SE)
Age at enrollment (years)
46.00 (0.68)
Annual household income (US dollars)
22360 (872.29)
Years of education
10.41 (0.15)
MET minutes/wk. of all activity
1913.02 (384.71)
MET minutes/wk. of moderate and vigorous activity
1217.83 (154.52)
Total cholesterol (mg/dL)
183.58 (1.14)
Triglycerides (mg/dL)
162.37 (3.62)
HDL cholesterol (mg/dL)
46.45 (0.38)
LDL cholesterol (mg/dL)
107.38 (1.00)
30.99 (0.21)
Body mass index (kg/m2 )
Waist circumference (cm)
102.87 (0.47)
Waist-to-hip ratio
0.93 (0.002)
Body fat (%)
35.59 (0.47)
C-reactive protein (mg/L)
3.90 (1.04)
Systolic blood pressure (mmHg)
116.92 (0.55)
Diastolic blood pressure (mmHg)
71.19 (0.32)
12.55 (1.02)
Insulin (mg/dL)3
Fasting blood glucose (mg/dL)3
105.64 (1.01)
HOMA IR3
3.29 (1.02)
HbA1c (%)3
5.53 (1.01)

Variable

Table 1: Cohort demographics and metabolic characteristics stratified by overweight/obese type and metabolic health status: Cameron County Health Cohort Study (2003–2014)1,2 .
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Table 2: Diabetes by overweight/obese type and metabolic health status.
Metabolically healthy
Normal weight
Overweight/obese
(𝑛 = 475)
(𝑛 = 1594)

Diabetes
Primary analysis
Frequency
Yes [𝑛, (%)]
No [𝑛, (%)]
Weighted OR (95% CI)
Unadjusted model
Multivariable adjusted model 13
Multivariable adjusted model 24
Sensitivity analysis5
Frequency
Yes [𝑛, (%)]
No [𝑛, (%)]
Weighted OR (95% CI)
Unadjusted model
Multivariable adjusted model 13
Multivariable adjusted model 24

Metabolically unhealthy
Normal weight
Overweight/obese
(𝑛 = 72)
(𝑛 = 1106)

P value

57 (12.00)
401 (84.42)

349 (21.89)
1208 (75.78)

26 (36.11)
42 (58.33)

446 (40.33)
641 (57.96)

<0.00011

Reference
Reference
Reference

2.30 (1.47, 3.60)
2.25 (1.34, 3.79)
2.14 (1.07, 4.28)

5.20 (2.41, 11.19)
3.78 (1.57, 9.09)
3.18 (1.02, 9.92)

6.23 (3.94, 9.85)
5.39 (3.16, 9.20)
5.01 (2.43, 10.34)

<0.00012
<0.00012
<0.00012

41 (9.53)
375 (87.21)

145 (12.49)
982 (84.58)

42 (35.90)
68 (58.12)

650 (42.24)
867 (56.34)

<0.00011

Reference
Reference
Reference

1.48 (0.87, 2.54)
1.47 (0.83, 2.61)
1.36 (0.59, 3.13)

4.25 (1.74, 10.37)
2.93 (1.04, 8.23)
3.23 (1.08, 10.01)

7.81 (4.56, 13.37)
6.25 (3.54, 11.02)
6.57 (2.81, 15.36)

<0.00012
<0.00012
<0.00012

1

𝐹 approximation of Rao-Scott design adjusted chi-square test P value.
P values from Wald chi-square test for the effect of overweight/obese phenotype.
3
Adjusted for age at enrollment. Other covariates were not significant and not included in the final model. The models were adjusted for the probability of
sampling using weights taking into consideration clustering effects arising from the same census block and household.
4
Adjusted for age at enrollment and family history of diabetes. Restricted to the participants who had data for family history of diabetes (𝑛 = 2,234, 68%).
5
The definition of metabolically health included glucose component.
2

Prevalence of diabetes (%)

45

40.33%

40

36.11%

35
30
25

21.89%

20
15

12.00%

10
5
0
Metabolically Metabolically Metabolically
healthy
unhealthy
healthy normal
normal
overweight/
weight
obese
weight
Overweight/obese phenotype

Metabolically
unhealthy
overweight/
obese

Figure 1: Prevalence of diabetes among Mexican Americans within
each overweight/obese phenotype. Black bars indicate prevalence
rate. Diabetes prevalence was different by overweight/obese phenotype (𝑃 < 0.0001).

3.78 (95% CI 1.57–9.09), and MUHOW subjects showed an
OR of 5.39 (95% CI 3.16–9.20) after adjusting for confounding factors with the MHNW phenotype as the reference
(Table 2). The biggest effect comes from being metabolically
unhealthy and normal weight: the adjusted odds ratio for
this group compared to the metabolically healthy and normal
weight one is 3.8, while the OR for metabolically unhealthy

and normal weight compared to metabolically healthy and
normal weight is just over 2 (Table 2). The addition of
metabolically unhealthy phenotypes to obesity increases the
OR for diabetes to over 5-fold (Table 2). The ORs for the
risk of diabetes were greater than 1 for the metabolically
unhealthy phenotype and were much higher than the ORs
for MHNW and MHOW phenotypes: the difference of ORs
between MUHNW and MHNW phenotypes was 278%; and
the difference of ORs between MUHOW and MHOW phenotypes was 140%, while the difference of ORs between MHOW
and MHNW phenotypes was 125%, and the difference of
ORs between MUHNW and MUHOW phenotypes was 43%.
These comparisons suggested that the risk of diabetes in
metabolically unhealthy phenotype was higher than healthy
phenotype in any category of BMI, and the metabolic health
is more important than simple overweight/obesity. Restricted
to the participants who had available data for family history
of diabetes (68%), the ORs in each phenotype were not
materially changed. When fasting blood glucose > 100 mg/dL
or being on hypoglycemic medication was included as a
component for the definition of metabolic health in the
sensitivity analysis, the correlation was not significant for
the MHOW phenotype, the correlation for the MUHNW
phenotype remained similar, and the correlation for the
MUHOW phenotype became slightly stronger. The sensitivity analysis results further suggested that the metabolic
health is more important than simple overweight/obesity.
Supplemental Table 2 further showed the risk of diabetes by
overweight, obese, and metabolic status. Similar patterns as
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Odds ratios
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300
280
260
240
220
200
180
160
140
120
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60
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55

60

65

70

Age at enrollment (years)
Metabolically healthy normal weight
Metabolically healthy overweight/obese
Metabolically unhealthy normal weight
Metabolically unhealthy overweight/obese

Figure 2: Smoothed plot for odds ratios (ORs) of the diabetes
risk according to age at enrollment. Subjects were divided into
four phenotypes according to overweight/obese phenotype and
metabolic health status. The ORs were estimated by using the
restricted cubic spline logistic regression models with knots placed
at the 5th, 50th, and 95th percentiles of age at enrollment. The
models were adjusted for the probability of sampling using weights
taking into consideration clustering effects arising from the same
census block and household. The linear correlation between age
at enrollment and the risk of diabetes in each phenotype was
significant (𝑃 = 0.02, 0.0001, 0.04, and <0.0001 for phenotypes
with metabolically healthy normal weight, metabolically healthy
overweight/obesity, metabolically unhealthy normal weight, and
metabolically unhealthy overweight/obesity, resp.).

in Table 2 indicated that the risk of diabetes in metabolically
unhealthy phenotype was higher than healthy phenotype,
and the metabolic health is more important than simple
overweight or obesity.
Figure 2 visually depicts the shape of the correlation
between age and diabetes risk in four phenotypes after adjusting for potential confounding variables in a restricted cubic
spline model. Age was positively and approximately linearly
associated with the risk for diabetes in each phenotype (all
Ps < 0.05). Metabolically unhealthy phenotypes had higher
ORs than their corresponding counterparts in any category
of BMI, and MUHNW phenotype had the highest ORs in
the four phenotypes. MHOW subjects had higher ORs than
MHNW subjects, and the latter had the lowest ORs in the four
phenotypes.

4. Discussion
In a Mexican American cohort metabolically unhealthy
subjects showed significantly increased risk for diabetes
compared with metabolically healthy subjects in any category
of BMI. Compared with the metabolically healthy normal
weight participants (MHNW), the metabolically unhealthy,
regardless of their BMI (MUHNW and MUHOW), and
the metabolically healthy obese (MHOW) phenotypes had

significantly increased risk of diabetes. MUHNW individuals
had a fourfold increased risk and MUHOW individuals had
a fivefold increased risk for diabetes compared with the
MHNW phenotype. Cubic spline interpolation showed that
the risk of diabetes with age was higher in metabolically
unhealthy phenotype than metabolically healthy phenotype
in any category of BMI. The significance of these observations
is that poor metabolic health puts the individual at greater
risk of diabetes than obesity alone.
A high proportion of the Mexican Americans in our
population are metabolically unhealthy (36.3%) but over
half (59.9%) if the definition of metabolic health includes
a glucose component. Because we wanted to examine the
relationship of diabetes, a disease of glucose metabolism, we
excluded that from our criteria for metabolic abnormalities,
yet metabolic abnormalities remain the major association
with diabetes. Others have shown a high prevalence of
metabolically unhealthy Mexican Americans (30%) [6]. In
general, Mexican Americans also have high prevalence of
diabetes, overweight/obesity, and metabolic abnormalities
compared to non-Hispanic Whites [14–16]. Using both logistic regression and cubic spline models, being metabolically
unhealthy posed a significantly higher risk for diabetes than
being overweight. Similar observations have been made in
a prospective cohort study in 6,748 Koreans [5], although
the results were not all statistically significant among different overweight/obese and metabolic health phenotypes [5].
Furthermore, we found that metabolically unhealthy overweight/obese individuals were more likely to develop incident
diabetes compared with their normal weight counterparts
which was consistent with other findings [4–6]. An important
element here is the identification of those with metabolic
risk factors but who are not obese since they are at high
risk for diabetes but less likely to be identified early and
provided prevention education. These individuals may well
be overlooked in screening programs.
It is not surprising that poor metabolic health puts the
individual at a higher risk of diabetes than overweight/obesity
alone. In our study, metabolically unhealthy phenotype
tended to do less exercise and had lower education and
less income level but had increased cigarette smoking compared with metabolically healthy phenotypes. In particular,
the MUHNW phenotype showed the lowest proportion of
subjects who met minimum recommendations for physical
activity of ≥600 MET-minutes/week despite their normal
weight, although physical activity was not significant in multivariable analysis for the risk of diabetes. Because physical
activity was not correlated with diabetes risk (𝑃 = 0.18) and
metabolic health (𝑃 = 0.07) in logistic regression models and
it was not statistically significant in the multivariable adjusted
model (𝑃 = 0.46), it was not adjusted for in the final model.
Metabolically unhealthy phenotype had higher markers
of inflammation which may be the key underlying pathology.
Metabolically unhealthy subjects showed significantly higher
levels of CRP compared with their metabolically healthy
counterparts, consistent with the known role of systemic
inflammation in the risk of diabetes. Several conditions that
are driven by inflammatory processes are also associated
with diabetes, including rheumatoid arthritis, gout, psoriasis,
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and Crohn’s disease, and various anti-inflammatory drugs
have been approved or are in late stages of development
for the treatment of these conditions [26]. Another important difference between metabolically healthy and unhealthy
phenotypes was markedly higher dyslipidemia, measured
as hypertriglyceridemia and low HDL-C, fasting glucose,
high blood pressure, or insulin resistance observed in the
metabolically unhealthy phenotype. These results suggest the
importance of lifestyle modification and control of systemic
inflammation in maintaining metabolic health and normoglycemia, not the simple reduction in body weight, although
physical activity was not significant in multivariable analysis
for the risk of diabetes.
Our study found a positive dose-response with approximately linear relationship between age and the risk of
diabetes in each phenotype, stratified by overweight/obesity
and metabolic health. Metabolically unhealthy phenotypes
had higher risk than their corresponding counterparts in any
category of BMI, and MUHNW phenotype had the highest
ORs in the four phenotypes. To our knowledge, this is the
first study to find the risk of diabetes with age higher in
metabolically unhealthy phenotypes than in metabolically
healthy phenotypes in any category of BMI. The Korean
Healthy Twin Study (𝑛 = 2,687) reported that the risk of
diabetes was 4.4-fold higher in MUHNW individuals than
in MHNW individuals and 3.3-fold higher in MUHOW
subjects than in MHNW subjects [27]. Despite a normal
weight identical to the MHNW subjects, MUHNW subjects
in our study presented an increased fasting serum insulin
and blood glucose, HOMA IR, and HbA1c. This phenomenon
may be associated with impaired insulin sensitivity (euglycemic hyperinsulinemic clamp or oral glucose tolerance
test) [11, 28]. Although the mechanism is still not clear, at least
we are now aware that the MUHNW individuals are a target
population in which to identify and to prevent diabetes [27].
Previous studies have suggested that metabolic healthy
overweight/obesity was not a benign condition [4–6].
MHOW individuals may be more likely to have diabetes
compared with metabolically healthy normal weight peers
[4, 6]. Our study found that MHOW subjects had a significant
2.14-fold elevated risk of diabetes (Table 2) and they were
more likely to do this before 50 years of age compared
with their MHNW counterparts (Figure 1). However, in our
sensitivity analysis including fasting glucose as a component
for the definition of metabolic health, the risk of diabetes
was not significant for the MHOW phenotype. Clearly, the
risk of diabetes in MHOW populations needs to be further
investigated.
Although a small proportion of the subjects (2.22%)
were classified as metabolically unhealthy normal weight
phenotype, their risk for diabetes was higher than MHNW
and MHOW (Table 2) and they had the highest ORs for
the correlation between age and diabetes risk in the four
phenotypes (Figure 2). The proportion might be increased if
there is no effort to protect this population, because these
subjects are not overweight or obese and they may escape
detection and therefore not benefit from adequate treatment
or prevention measures. Furthermore, the interventions to
boost metabolic health involved changes in lifestyles such as
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diet, exercise, and behavior (smoking and others) which may
not be related to overweight/obesity [29]. Therefore, it is very
important to make efforts on improving metabolic health in
any categories of BMI. The MUHNW phenotype needs to
be included within the scope of prevention and control, but
should not be ignored.
There are some methodological limitations in our
research. The study was cross-sectional in design; thus, only
association but not causal relationship may be inferred.
Prospective studies are needed to further investigate whether
metabolic health is more important than overweight/obesity
alone. Our longitudinal data currently being collected will
provide that opportunity. We could not completely rule out
the possibility of residual confounding due to unmeasured or
inadequately measured covariates such as the missing values
with some variables.
This study had several strengths. First, this is a general population-based randomly selected Mexican American
cohort, thus avoiding bias inherent in studies drawn from
clinic populations or other nonrandomly selected populations with established disease or mixed ethnicity. Second,
detailed information on a wide range of factors related
to diabetes was available, allowing us to get a relatively
comprehensive analysis of the affecting factors. Third, cubic
spline interpolation was used to compare the dose-response
correlation between age and the diabetes risk in different
metabolic health and overweight/obese phenotypes and suggested the importance of metabolic health compared to
overweight/obesity for the risk of diabetes associated with
age. Finally, published studies generally only compared the
disease status between obesity (BMI ≥ 30 kg/m2 ) and normal
weight phenotypes stratified by the metabolic health status,
while the risk of diseases for the phenotype with BMI 25–
30 kg/m2 was neglected [6, 30]. However, previous studies
[2, 3] and our study found that overweight/obese individuals
(BMI ≥ 25 kg/m2 ) were at a higher risk of diabetes compared
with normal weight individuals.
In conclusion, in our cohort those who had more than two
markers indicating unhealthy metabolism had statistically
higher prevalence and odds of having diabetes compared
to those with healthy metabolism suggesting a higher risk
of diabetes adjusting for age, gender or BMI, and overweight/obese. Therefore, being metabolically unhealthy is
likely more important for the risk of diabetes than simply being overweight/obese. Efforts need to be focused on
improving metabolic health in all categories of BMI. Early
lifestyle intervention in these populations is likely to be more
effective than simple weight loss.
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